Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
Executive Summary
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.